Inactive Instrument

Press Releases Neurotrope Inc Other OTC

Equities

US64129T2078

End-of-day quote Other OTC Other stock markets
- ^USD	-

2020	Neurotrope, Inc. completed the spin-off of Neurotrope Bioscience, Inc.	CI
2020	Metuchen Pharmaceuticals LLC completed the acquisition of Neurotrope, Inc. from Intracoastal Capital LLC and others in a reverse merger transaction.	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

NEUROTROPE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	25/11/20	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	24/11/20	AQ
NEUROTROPE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	20/11/20	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	09/11/20	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	30/09/20	AQ
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	30/09/20	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	10/08/20	AQ
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	29/07/20	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	24/07/20	AQ
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	24/07/20	AQ
Neurotrope : Announces Strategic Partnership with BryoLogyx for Supply of Synthetic Bryostatin-1 and Continuation of the National Cancer Institute Trial for Childhood Leukemia	15/06/20	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	12/06/20	AQ
NEUROTROPE, INC. : Regulation FD Disclosure, Other Events (form 8-K)	28/05/20	AQ
Neurotrope : Launches New Long-Term Clinical Trial of Bryostatin with the National Institutes of Health for the Treatment of Patients with Alzheimer’s Disease	28/05/20	PU
NEUROTROPE, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	18/05/20	AQ
NEUROTROPE, INC. : Other Events (form 8-K)	11/05/20	AQ
NEUROTROPE : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	13/03/20	AQ
NEUROTROPE, INC. : Change in Directors or Principal Officers (form 8-K)	27/02/20	AQ
NEUROTROPE, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	26/02/20	AQ
Neurotrope : Provides Corporate Update after Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's disease Trial	24/01/20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Neurotrope Inc Other OTC

Equities

US64129T2078

Press Releases

Filters